The Effect of Intravenous Nalbuphine on PONV With Intrathecal Morphine in Abdominoplasty.

The Effect of Intravenous Nalbuphine on Postoperative Nausea and Vomiting With Intrathecal Morphine in Abdominoplastic Surgery.

Status

UNKNOWN

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT03786562

Enrollment

Registered

2018-12-26

Start date

2019-03-08

Completion date

2020-09-30

Last updated

2020-03-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Abdominal Obesity

Brief summary

How effectively intravenous nalbuphine can reduce the incidence of PONV after intrathecal administration of morphine in abdominoplastic surgery.

Interventions

DRUGIntrathecal Morphine

Group 1

DRUGIntrathecal Morphine + Intravenous Nalbuphine

Group 2

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

PREVENTION

Masking

QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender

FEMALE

Age

20 Years to 50 Years

Healthy volunteers

Inclusion criteria

* Patients undergoing abdominoplasty under spinal anesthesia * American Society of Anesthesiologists (ASA) class I and II.

Exclusion criteria

* allergy to local anesthetics * bleeding diatheses * local infection or sepsis

Design outcomes

Primary

Measure	Time frame	Description
postoperative nausea and vomiting	24 hours	A verbal descriptive scale (VDS) was used to assess the severity of PONV. ( no nausea=0, severe nausea= 10) by postoperative nausea and vomiting scale which range (o no nasuea to 10 sever vomating). A verbal descriptive scale (VDS) was used to assess the severity of PONV .

Secondary

Measure	Time frame	Description
postoperative pain and puririts.	24 hours	Visual analogue scale (VAS) pain scores (no pain = 0, worst possible pain = 10).

Countries

Egypt

Contacts

Primary ContactMohamed Bakri, Prof

mhbakri@gmail.com+20882413201

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026